ACH
XERS icon

ArrowMark Colorado Holdings’s Xeris Biopharma Holdings XERS Stock Holding History

ArrowMark Colorado Holdings’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,815,091
Closed -$7.39M – 371
2021
Q2 		$7.39M Sell
1,815,091
-65,631
-3% -$250K 0.06% 229
2021
Q1 		$8.48M Sell
1,880,722
-101,187
-5% -$546K 0.06% 208
2020
Q4 		$9.75M Sell
1,981,909
-93,478
-5% -$468K 0.08% 176
2020
Q3 		$12.3M Sell
2,075,387
-187,221
-8% -$749K 0.12% 131
2020
Q2 		$6.02M Sell
2,262,608
-79,294
-3% -$276K 0.06% 177
2020
Q1 		$4.57M Buy
2,341,902
+413,594
+21% +$1.78M 0.06% 178
2019
Q4 		$13.6M Buy
1,928,308
+271,886
+16% +$2.24M 0.12% 141
2019
Q3 		$16.3M Buy
1,656,422
+248,636
+18% +$2.79M 0.16% 119
2019
Q2 		$16.1M Buy
1,407,786
+8,075
+0.6% +$84.8K 0.15% 129
2019
Q1 		$14.1M Buy
1,399,711
+746,963
+114% +$9.57M 0.13% 137
2018
Q4 		$11.1M Buy
652,748
+21,512
+3% +$432K 0.12% 163
2018
Q3 		$11.1M Buy
631,236
+36,034
+6% +$782K 0.09% 192
2018
Q2 		$11.3M Buy
+595,202
New +$11.6M 0.1% 180

Other funds holding XERS

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

ArrowMark Colorado Holdings's XERS Position: Q3 2021 in Review

ArrowMark Colorado Holdings sold out of Xeris Biopharma Holdings (XERS) in Q3 2021, closing a stake of 1,815,091 shares — an estimated $7.39M sold.

ArrowMark Colorado Holdings first reported a position in XERS in Q2 2018 and held it in 13 quarters. The position peaked at $16.3M in Q3 2019. 70 funds tracked by Wall St. Rank hold XERS as of Q3 2021.

  • ArrowMark Colorado Holdings reported no remaining Xeris Biopharma Holdings position as of Q3 2021 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 1,815,091 Xeris Biopharma Holdings shares in Q3 2021, an estimated $7.39M.
  • ArrowMark Colorado Holdings first reported a position in Xeris Biopharma Holdings in Q2 2018 and held it in 13 quarters.
  • ArrowMark Colorado Holdings's Xeris Biopharma Holdings position peaked at $16.3M in Q3 2019.
  • 70 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2021.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.